T1	Participants 96 124	nodular basal cell carcinoma
T2	Participants 210 244	nodular basal cell carcinoma (BCC)
T3	Participants 735 750	Twenty patients
T4	Participants 1011 1026	Twenty patients
T5	Participants 1050 1068	imiquimod (n = 10)
T6	Participants 1072 1088	vehicle (n = 10)
T7	Participants 792 804	imiquimod 5%
T8	Participants 808 821	vehicle cream
